Journal Title:Hepatic Medicine-evidence And Research
Hepatic Medicine Evidence and Research is an international peer-reviewed medical journal dedicated to liver disease, dedicated to publishing clinical studies, case reports, reviews, and expert opinions on liver disease. This journal emphasizes evidence-based medical practice, aiming to provide scientific basis for the prevention, diagnosis, and treatment of liver diseases. It covers research on various liver diseases, from viral hepatitis to fatty liver, cirrhosis, and liver cancer, and is an important source of information for liver specialists and researchers.
The characteristic of the magazine lies in its emphasis on high-quality clinical research, which can directly affect clinical decision-making and patient care. The editorial committee of the journal is composed of internationally renowned liver disease experts, ensuring the scientific and practical nature of the published articles. In addition, the journal is indexed in multiple databases, including PubMed Central, which increases its visibility and influence in the international medical community. It is one of the authoritative journals in the field of liver disease and a valuable resource for medical professionals who wish to access the latest clinical research and treatment progress. By reading this journal, professionals can maintain an understanding of the latest research in the field of liver disease treatment and apply this knowledge to their daily clinical practice.
《肝病醫(yī)學證據(jù)與研究》是一本專注于肝臟疾病的國際同行評審醫(yī)學期刊,它致力于發(fā)表關(guān)于肝臟疾病的臨床研究、病例報告、綜述和專家意見等內(nèi)容。該期刊強調(diào)基于證據(jù)的醫(yī)療實踐,旨在為肝臟疾病的預(yù)防、診斷和治療提供科學依據(jù)。它覆蓋了從病毒性肝炎到脂肪肝、肝硬化以及肝癌等多種肝臟疾病的研究,是肝臟??漆t(yī)生和研究人員的重要信息來源。
雜志的特點在于其對高質(zhì)量臨床研究的重視,這些研究能夠直接影響臨床決策和患者護理。期刊的編輯委員會由國際知名的肝臟疾病專家組成,確保了發(fā)表文章的科學性和實用性。此外,該期刊被多個數(shù)據(jù)庫收錄,包括PubMed Central,這增加了其在國際醫(yī)學界的可見度和影響力。它是肝臟疾病領(lǐng)域的權(quán)威期刊之一,對于希望獲取最新臨床研究和治療進展的醫(yī)療專業(yè)人員來說,是一個寶貴的資源。通過閱讀該期刊,專業(yè)人士可以保持對肝臟疾病治療領(lǐng)域最新研究的了解,并將這些知識應(yīng)用于日常的臨床實踐中。
Hepatic Medicine-evidence And Research由Dove Medical Press出版商出版,收稿方向涵蓋GASTROENTEROLOGY & HEPATOLOGY全領(lǐng)域,平均審稿速度 16 Weeks ,影響因子指數(shù)2.6,該期刊近期沒有被列入國際期刊預(yù)警名單,廣大學者值得一試。
按JIF指標學科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學科:GASTROENTEROLOGY & HEPATOLOGY | ESCI | Q2 | 67 / 143 |
53.5% |
按JCI指標學科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學科:GASTROENTEROLOGY & HEPATOLOGY | ESCI | Q3 | 96 / 143 |
33.22% |
名詞解釋:
WOS即Web of Science,是全球獲取學術(shù)信息的重要數(shù)據(jù)庫,Web of Science包括自然科學、社會科學、藝術(shù)與人文領(lǐng)域的信息,來自全世界近9,000種最負盛名的高影響力研究期刊及12,000多種學術(shù)會議多學科內(nèi)容。給期刊分區(qū)時會按照某一個學科領(lǐng)域劃分,根據(jù)這一學科所有按照影響因子數(shù)值降序排名,然后平均分成4等份,期刊影響因子值高的就會在高分區(qū)中,最后的劃分結(jié)果分別是Q1,Q2,Q3,Q4,Q1代表質(zhì)量最高。
是否OA開放訪問: | h-index: | 年文章數(shù): |
開放 | -- | 21 |
Gold OA文章占比: | 2021-2022最新影響因子(數(shù)據(jù)來源于搜索引擎): | 開源占比(OA被引用占比): |
100.00% | 2.6 | |
研究類文章占比:文章 ÷(文章 + 綜述) | 期刊收錄: | 中科院《國際期刊預(yù)警名單(試行)》名單: |
61.90% | SCIE | 否 |
歷年IF值(影響因子):
歷年引文指標和發(fā)文量:
歷年自引數(shù)據(jù):
若用戶需要出版服務(wù),請聯(lián)系出版商。